Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Adv ; 6(49)2020 Dec.
Article in English | MEDLINE | ID: mdl-33277259

ABSTRACT

Transmission electron microscopy went through a revolution enabling routine cryo-imaging of biological and (bio)chemical systems, in liquid form. Yet, these approaches typically lack advanced analytical capabilities. Here, we used atom probe tomography to analyze frozen liquids in three dimensions with subnanometer resolution. We introduce a specimen preparation strategy using nanoporous gold. We report data on 2- to 3-µm-thick layers of ice formed from both high-purity deuterated water and a solution of 50 mM NaCl in high-purity deuterated water. The analysis of the gold-ice interface reveals a substantial increase in the solute concentrations across the interface. We explore a range of experimental parameters to show that atom probe analyses of bulk aqueous specimens come with their own challenges and discuss physical processes that produce the observed phenomena. Our study demonstrates the viability of using frozen water as a carrier for near-atomic-scale analysis of objects in solution by atom probe tomography.

2.
Soft Matter ; 13(9): 1759-1763, 2017 Mar 01.
Article in English | MEDLINE | ID: mdl-28097280

ABSTRACT

The self-assembly of amphiphilic molecules usually takes place in a liquid phase, near room temperature. Here, using small angle X-ray scattering (SAXS) experiments performed in real time, we show that freezing of aqueous solutions of copolymer amphiphilic molecules can induce self-assembly below 0 °C.

3.
Vet Immunol Immunopathol ; 157(3-4): 164-74, 2014 Feb 15.
Article in English | MEDLINE | ID: mdl-24445196

ABSTRACT

Rhodococcus equi is the most common infectious cause of mortality in foals between 1 and 6 months of age. Because of an increase in the number of antibiotic-resistant strains, the optimization of a prophylactic strategy is a key factor in the comprehensive management of R. equi pneumonia. The objectives of this study were to assess the safety and immunogenicity of R. equi-secreted proteins (ReSP) co-administered with either the nanoparticular adjuvant Montanide™ IMS 3012 VG, or a new polymeric adjuvant Montanide™ PET GEL A, and to further investigate the most immunogenic proteins for subsequent immunization/challenge experiments in the development of a vaccine against rhodoccocal pneumonia. The approach involved two phases. The first phase aimed to investigate the safety of vaccination in six adult horses. The second phase aimed to determine the safety and immunogenicity of vaccination in twelve 3-week-old foals. We set out to develop a method based on ultrasound measurements for safety assessment in adult horses in order to evaluate any in situ changes at the injection site, in the skin or the underlying muscle, with quantitative and qualitative data revealing that administration of ReSP combined with the Pet Gel A adjuvant led to an increase in local inflammation, associated with 4- to 7-fold higher levels of anti-R. equi IgGa, IgGb and IgGT, compared to administration of ReSP associated with IMS 3012 adjuvant, but without any impact on animal demeanor. Investigations were then performed in foals with serological and clinical follow-up until 6 months of age. Interestingly, we observed in foals a much lower incidence of adverse local tissue reactions at the injection site than in adult horses, with transient and moderate swelling for the group that received ReSP combined with Pet Gel A. Immunized foals with Pet Gel A adjuvant exhibited a similar response in both IgGa and IgGT levels, but a lower response in IgGb levels, compared to adult horses, with a subisotype profile that may however reflect a bias favorable to R. equi resistance. From the crude extract of secreted proteins, dot-blot screening enabled identification of cholesterol oxidase, mycolyl transferase 3, and PSP (probable secreted protein) as the most immunogenic candidates. Taken together, these results are encouraging in developing a vaccine for foals.


Subject(s)
Bacterial Proteins/immunology , Bacterial Vaccines/immunology , Rhodococcus equi/immunology , Adjuvants, Immunologic/administration & dosage , Animals , Bacterial Vaccines/adverse effects , Horses , Immunoglobulin G/blood , Immunoglobulin G/classification , Nanoparticles/administration & dosage , Polymers/administration & dosage
4.
J Microsc ; 244(1): 93-100, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21711462

ABSTRACT

Sintering of green samples of alumina produced by ice-templating was followed in situ in an environmental scanning electron microscope (ESEM) up to temperatures as high as 1375°C. These alumina samples with well-defined architectures are of great interest in the field of materials science due to their high specific strength (especially in compression), low density and adaptable porosity. For the present study, they also have the advantage to exhibit an important topography, inducing interesting contrast when imaged in an ESEM. Improvements of the imaging conditions in the ESEM were essential to really follow the sintering process involving formation of necks between grains or shift of the centre of grains. This paper describes the improvements made and the results observed on the sintering process of alumina green samples processed by ice-templating.

5.
Onderstepoort J Vet Res ; 76(3): 299-309, 2009 Sep.
Article in English | MEDLINE | ID: mdl-21105597

ABSTRACT

The present study was designed to assess and compare three different formulations of the new Onderstepoort infectious coryza (IC) quadrivalent vaccine, which contain an NAD-independent strain of Avibacterium paragallinarum (previously known as Haemophilus paragallinarum), and a commercial IC vaccine, not containing an NAD-independent strain, for their safety and ability to protect chickens of varying ages against virulent challenges with four different serovars of A. paragallinarum, including the NAD-independent strain of the C-3 serovar. Four groups of 140 chickens each were vaccinated at the age of 17 weeks and revaccinated at the age of 19 weeks with each of the four vaccine formulations. A similar sized group of non-vaccinated chickens was used as control. Two rounds of challenge were conducted: a group of chicken in each vaccination group was challenged between 31 and 35 weeks of age, while another group was challenged between 51 and 55 weeks of age. The "in-contact" challenge model was used in this experiment. For each vaccination group, the four challenge strains representing four local serovars were used in each challenge round. The efficacy of the vaccines was compared based on overall protection levels obtained and the duration of protection. The safety of the different vaccines was determined by the severity of post-vaccination reactions. The need for the incorporation of the NAD-independent strain in the vaccine was evidenced by the low protection level against NAD-independent challenge recorded in the group of birds vaccinated with the commercial vaccine. The results obtained confirmed not only the variation in virulence of different South African serovars, with serovar C-3 being the most virulent and serovar B having almost no virulence but also the age related increase in susceptibility. The importance of a suitable formulation of the vaccine is discussed.


Subject(s)
Chickens , Haemophilus Infections/veterinary , Haemophilus paragallinarum/immunology , Haemophilus paragallinarum/pathogenicity , Picornaviridae Infections/veterinary , Poultry Diseases/prevention & control , Animals , Bacterial Vaccines , Haemophilus Infections/immunology , Haemophilus Infections/microbiology , Haemophilus Infections/prevention & control , Haemophilus paragallinarum/metabolism , NAD/metabolism , Picornaviridae Infections/immunology , Picornaviridae Infections/prevention & control , Poultry Diseases/immunology , Poultry Diseases/microbiology , Random Allocation , Rhinovirus , Treatment Outcome , Vaccination/standards , Vaccination/veterinary , Viral Vaccines
6.
J Biomed Mater Res A ; 83(2): 434-45, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17465019

ABSTRACT

A key issue for the fabrication of scaffolds for tissue engineering is the development of processing techniques flexible enough to produce materials with a wide spectrum of solubility (bioresorption rates) and mechanical properties matching those of calcified tissues. These techniques must also have the capability of generating adequate porosity to further serve as a framework for cell penetration, new bone formation, and subsequent remodeling. In this study we show how hybrid organic/inorganic scaffolds with controlled microstructures can be built using robotic assisted deposition at room temperature. Polylactide or polycaprolactone scaffolds with pore sizes ranging between 200-500 microm and hydroxyapatite contents up to 70 wt % were fabricated. Compressive tests revealed an anisotropic behavior of the scaffolds, strongly dependant on their chemical composition. The inclusion of an inorganic component increased their stiffness but they were not brittle and could be easily machined even for ceramic contents up to 70 wt %. The mechanical properties of hybrid scaffolds did not degrade significantly after 20 days in simulated body fluid. However, the stiffness of pure polylactide scaffolds increased drastically due to polymer densification. Scaffolds containing bioactive glasses were also printed. After 20 days in simulated body fluid they developed an apatite layer on their surface.


Subject(s)
Biocompatible Materials/metabolism , Robotics/methods , Body Fluids/metabolism , Ceramics/metabolism , Compressive Strength , Glass , Hardness , Humans , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Polyesters/chemistry , Transition Temperature
7.
Nano Lett ; 5(7): 1297-301, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16178227

ABSTRACT

Oxide ceramics are sensitive to slow crack growth because adsorption of water can take place at the crack tip, leading to a strong decrease of the surface energy in humid (or air) conditions. This is a major drawback concerning demanding, long-term applications such as orthopaedic implants. Here we show that a specific nanostructuration of ceramic oxides can lead to a crack resistance never reached before, similar to that of covalent ceramics.


Subject(s)
Aluminum Oxide/chemistry , Biocompatible Materials/chemistry , Ceramics/chemistry , Crystallization/methods , Nanostructures/chemistry , Zirconium/chemistry , Aluminum Oxide/analysis , Biocompatible Materials/analysis , Ceramics/analysis , Hardness , Materials Testing , Molecular Conformation , Nanostructures/analysis , Oxides/analysis , Oxides/chemistry , Surface Properties , Water/chemistry , Zirconium/analysis
8.
Expert Rev Vaccines ; 1(1): 111-8, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12908518

ABSTRACT

The development of adjuvants will represent a major challenge for this century. Indeed the need for safer vaccines leads to the development of a new generation of antigens like synthetic peptide, recombinant proteins or even vectored DNA. However, this is to the detriment of their immunogenicity. The addition of adjuvant is becomes necessary to enhance immune responses and improve vaccine potency. However, adjuvants can be responsible for the apparition of secondary reactions and they must be adapted according to various criteria such as the route of immunization, the type of the immune response, the duration of immunity, or the quality of the antigen, in order to get the best balance between efficacy and safety.


Subject(s)
Adjuvants, Immunologic/pharmacology , Mannitol/analogs & derivatives , Mannitol/pharmacology , Oleic Acids/pharmacology , Vaccines/immunology , Adjuvants, Immunologic/adverse effects , Adjuvants, Immunologic/chemistry , Drug Stability , Emulsions , Humans , Mannitol/adverse effects , Oils , Oleic Acids/adverse effects , Vaccines/administration & dosage , Water
9.
Parasite ; 8(2 Suppl): S126-32, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11484335

ABSTRACT

Trichinellosis, a re-emerging zoonosis in several countries and pig, is the main species responsible for its transmission to human. Vaccination of swine could be an alternative to prevent the risk of human contamination. In order to develop an efficient and safe inactivate vaccine, the choice of the adjuvant is an important issue. The aim of this study was to develop and select potent and safe adjuvants by screening them in an experimental model with a crude soluble antigen from L1 muscular larvae (ML) of Trichinella spiralis (Ts). The efficacy was checked by the quantification of specific antibody levels. Specific and non-specific IgE antibody levels were also assessed. Safety was checked by the assessment of the local reaction at the injection site. Various Montanide ISA adjuvant formulations including water in oil, oil in water and multiphasic emulsions, but also nanoparticles or microbeads were tested. The results clearly showed differences between the antibody responses induced by the adjuvants and demonstrated the necessity to use an adjuvant to obtain a specific IgG (IgG1 or IgG2a) response directed against the total soluble extract of Ts. All the formulations enhanced the humoral immune response. The origin of the oil contained in the emulsions played an important role on the efficacy. Indeed emulsions based on mineral oils were more efficient than those based on metabolisable oils. However it was linked with stronger local reactions. Multiphasic and oil in water emulsions but also nanoparticles failed to induce IgG2a antibody levels. Microbeads and water in oil formulations based on mineral oils were more efficient. This experimentation allowed then the selection of several adjuvants which efficacy will be further investigated by a challenge test and an analysis of the cellular populations involved in the mechanism of the immune response.


Subject(s)
Adjuvants, Immunologic , Trichinella spiralis/immunology , Trichinellosis/immunology , Vaccines, Inactivated , Animals , Female , Humans , Mannitol/analogs & derivatives , Mice , Mice, Inbred Strains , Oleic Acids , Safety , Trichinellosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...